Genitourinary Cancer
Supplements
Cancer Data Trends 2023
Article
Promising New Approaches for Testicular and Prostate Cancer
Conference Coverage
Multiprong strategy makes clinical trials less White
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
Conference Coverage
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
News
FDA approves talazoparib for metastatic prostate cancer
The new approval is based on findings from the randomized, placebo-controlled, phase 3 TALAPRO-2 trial.
News
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get meds
On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags...
Conference Coverage
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology
A pair of new studies show that drugs can reduce cancer risk when cells are elusive.
News
Widespread carboplatin, cisplatin shortages: NCCN survey
Only 64% of centers said they are still able to continue treating all current patients receiving carboplatin.
News
Risk of falls seen with newer antiandrogens for prostate cancer
The take-home message is that the findings give men – and the physicians who counsel them – a fuller idea of what to expect when considering using...
News
Posluma approved for PET imaging in prostate cancer
“The study showed that Posluma PET provided clinically valuable information prior to surgery that would likely result in management changes for...